Aerosol Delivery During High Frequency Jet Ventilation: An MRI Evaluation

References

1. 1.↵
   1. Walmrath D,
   2. Schermuly R,
   3. Pilch J,
   4. Grimminger F,
   5. Seeger W

   . Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 1997;10(5):1084–2092.

   OpenUrlAbstract
2. 2.
   1. Meyer J,
   2. Theilmeier G,
   3. Van Aken H,
   4. Bone HG,
   5. Busse H,
   6. Waurick R,
   7. et al

   . Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure. Anesth Analg 1998;86(4):753–758.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Putensen C,
   2. Hormann C,
   3. Kleinsasser A,
   4. Putensen-Himmer G

   . Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157(6 Pt 1):1743–1747.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Sood BG,
   2. Delaney-Black V,
   3. Aranda JV,
   4. Shankaran S

   . Aerosolized PGE₁: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a phase I/II open label clinical trial. Pediatr Res 2004;56(4):579–585.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Sood BG,
   2. Glibetic M,
   3. Aranda JV,
   4. Delaney-Black V,
   5. Chen X,
   6. Shankaran S

   . Systemic levels following PGE1 inhalation in neonatal hypoxemic respiratory failure. Acta Paediatr 2006;95(9):1093–1098.

   OpenUrlPubMed
6. 6.↵
   1. Sood BG,
   2. Peterson J,
   3. Malian M,
   4. Galli R,
   5. Geisor-Walter M,
   6. McKinnon J,
   7. et al

   . Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res 2007;56(6):531–541.

   OpenUrlPubMed
7. 7.↵
   1. Sood BG,
   2. Dawe EJ,
   3. Rao Maddipati K,
   4. Malian M,
   5. Chen X,
   6. Galli R,
   7. et al

   . Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs. Pulm Pharmacol Ther 2008;21(3):565–572.

   OpenUrlPubMed
8. 8.↵
   1. Sood BG,
   2. Shen Y,
   3. Latif Z,
   4. Chen X,
   5. Sharp J,
   6. Neelavalli J,
   7. et al

   . Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res 2008;64(2):159–164.

   OpenUrlPubMed
9. 9.↵
   1. Sood BG,
   2. Shen Y,
   3. Latif Z,
   4. Galli R,
   5. Dawe EJ,
   6. Haacke EM

   . MRI validation of aerosol delivery during high frequency ventilation in neonatal pigs. Respirology 2010;15(3):551–555.

   OpenUrlPubMed
10. 10.↵
    1. Mazela J,
    2. Polin RA

    . Aerosol delivery to ventilated newborn infants: historical challenges and new directions. Eur J Pediatr 2011;170(4):433–444.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. O'Riordan TG,
    2. Palmer LB,
    3. Smaldone GC

    . Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 1994;149(1):214–219.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Dhand R

    . Basic techniques for aerosol delivery during mechanical ventilation. Respir Care 2004;49(6):611–622.

    OpenUrlPubMed
13. 13.
    1. Stuart BO

    . Deposition of inhaled aerosols. Arch Intern Med 1973;131(1):60–73.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Newman SP,
    2. Wilding IR

    . Imaging techniques for assessing drug delivery in man. Pharm Sci Technol Today 1999;2(5):181–189.

    OpenUrlCrossRefPubMed
15. 15.
    1. Kim CS

    . Methods of calculating lung delivery and deposition of aerosol particles. Respir Care 2000;45(6):695–711.

    OpenUrlPubMed
16. 16.
    1. Sangwan S,
    2. Condos R,
    3. Smaldone GC

    . Lung deposition and respirable mass during wet nebulization. J Aerosol Med 2003;16(4):379–386.

    OpenUrlPubMed
17. 17.
    1. Dubus JC,
    2. Vecellio L,
    3. De Monte M,
    4. Fink JB,
    5. Grimbert D,
    6. Montharu J,
    7. et al

    . Aerosol deposition in neonatal ventilation. Pediatr Res 2005;58(1):10–14.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Finlay WH,
    2. Stapleton KW,
    3. Chan HK,
    4. Zuberbuhler P,
    5. Gonda I

    . Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling. J Appl Physiol 1996;81(1):374–383.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    Alternative routes of drug administration: advantages and disadvantages (subject review). American Academy of Pediatrics. Committee on Drugs. Pediatrics 1997;100(1):143–152.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Ari A,
    2. Atalay OT,
    3. Harwood R,
    4. Sheard MM,
    5. Aljamhan EA,
    6. Fink JB

    . Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845–851.

    OpenUrlPubMed
21. 21.↵
    1. Misselwitz B,
    2. Muhler A,
    3. Heinzelmann I,
    4. Bock JC,
    5. Weinmann HJ

    . Magnetic resonance imaging of pulmonary ventilation. Initial experiences with a gadolinium-DTPA-based aerosol. Invest Radiol 1997;32(12):797–801.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    Vortran Medical Technology MiniNEB 510(k) submission to the Food and Drug Administration, Center for Device and Radiological Health, Office of Device Evaluation. 1992.
23. 23.↵
    1. Ferrante S,
    2. Painter E

    . Continuous nebulization: a treatment modality for pediatric asthma patients. Pediatr Nurs 1995;21(4):327–331.

    OpenUrlPubMed
24. 24.
    1. Dijk PH,
    2. Heikamp A,
    3. Bambang Oetomo S

    . Surfactant nebulisation: lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits. Intensive Care Med 1997;23(10):1070–1076.

    OpenUrlCrossRefPubMed
25. 25.
    1. Brown B,
    2. Harwood B

    . An in vitro comparison of two methods of aerosolized bronchodilator delivery to intubated mechanically ventilated neonates (abstract). Respir Care 1998;43(10):844.

    OpenUrl
26. 26.
    1. Cheney S,
    2. Crezee K,
    3. Macknight T,
    4. Wright J

    . Comparing pressure changes and aerosol deposition of a standard small-volume nebulizer and a Mini-HEART low flow nebulizer during HFOV (abstract). Respir Care 2009;54(11):1524.

    OpenUrl
27. 27.
    1. Sood BG,
    2. Chen X,
    3. Dawe EJ,
    4. Malian M,
    5. Maddipati KR

    . Tissue distribution, metabolism and excretion of PGE1 following prolonged high-dose inhalation in neonatal pigs. Int J Pharmacol 2010;6(3):224–230.

    OpenUrl
28. 28.↵
    1. Lewis J,
    2. Ikegami M,
    3. Higuchi R,
    4. Jobe A,
    5. Absolom D

    . Nebulized vs instilled exogenous surfactant in an adult lung injury model. J Appl Physiol 1991;71(4):1270–1276.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Siobal MS,
    2. Kallet RH,
    3. Pittet JF,
    4. Warnecke EL,
    5. Kraemer RW,
    6. Venkayya RV,
    7. et al

    . Description and evaluation of a delivery system for aerosolized prostacyclin. Respir Care 2003;48(8):742–753.

    OpenUrlAbstract/FREE Full Text
30. 30.
    1. Coleman DM,
    2. Kelly HW,
    3. McWilliams BC

    . Determinants of aerosolized albuterol delivery to mechanically ventilated infants. Chest 1996;109(6):1607–1613.

    OpenUrlCrossRefPubMed
31. 31.
    1. Di Paolo ER,
    2. Pannatier A,
    3. Cotting J

    . In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation. Pediatr Crit Care Med 2005;6(4):462–469.

    OpenUrlPubMed
32. 32.
    1. Dijk PH,
    2. Heikamp A,
    3. Piers DA,
    4. Weller E,
    5. Bambang Oetomo S

    . Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition. Intensive Care Med 1997;23(4):456–462.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.
    1. McPeck M,
    2. Tandon R,
    3. Hughes K,
    4. Smaldone GC

    . Aerosol delivery during continuous nebulization. Chest 1997;111(5):1200–1205.

    OpenUrlCrossRefPubMedWeb of Science
34. 34.
    1. Pelkonen AS,
    2. Nikander K,
    3. Turpeinen M

    . Jet nebulization of budesonide suspension into a neonatal ventilator circuit: synchronized versus continuous nebulizer flow. Pediatr Pulmonol 1997;24(4):282–286.

    OpenUrlPubMed
35. 35.
    1. Fok TF,
    2. Monkman S,
    3. Dolovich M,
    4. Gray S,
    5. Coates G,
    6. Paes B,
    7. et al

    . Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21(5):301–309.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Dolovich MB,
    2. Millar D,
    3. Sterling L,
    4. Rhem R,
    5. Bosco AP,
    6. Kirpalani H

    . Lung deposition of QVAR (HFA134A-BDP) in newborn infants with bronchopulmonary dysplasia (BPD). Chest 2005;128;4(Suppl):351S.

    OpenUrl
37. 37.↵
    1. Davies J,
    2. Williford L,
    3. Bartle R,
    4. Stallings R,
    5. Pagnanelli R,
    6. MacIntyre N

    . Aerosol delivery during high frequency oscillatory and jet ventilation (abstract). Respir Care 2011;56(11):1700.

    OpenUrl
38. 38.↵
    1. Fink JB,
    2. Dhand R,
    3. Grychowski J,
    4. Fahey PJ,
    5. Tobin MJ

    . Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 1999;159(1):63–68.

    OpenUrlPubMed